Anest. intenziv. Med. 2006;17(2):99-101

Renal replacement therapy in critically ill patients: 2005 updateIntensive Care Medicine

I. Novák, M. Matějovič, A. Kroužecký, J. Raděj
Jednotka intenzivní péče I. interní kliniky, Fakultní nemocnice a Lékařská fakulta UK, Plzeň

Renal replacement therapy (RRT) is needed in 50% to 70% of patients with sepsis-related acute renal failure (ARF) in the ICU. The ARF in this setting is often accompanied by multiple organ dysfunction and is associated with very high mortality (53% to 73%). Thus, there is a great deal of interest in developing renal replacement strategies to reduce the mortality rate.Traditional intermittent haemodialysis in the treatment of ARF offers good metabolic control but poor haemodynamic tolerance, especially in septic patients. Haemofiltration is the more commonly used method in septic shock due to its better haemodynamic tolerance, and it is argued that haemofiltration can reverse the sepsis-related inflammatory response, even in the absence of ARF.This emphasises the potential role of the early initiation of haemofiltration in sepsis. Some new developments in blood purification for sepsis, including high-flux haemofiltration, high-volume haemofiltration, and the use of sorbents, remain under investigations. Current evidence is insufficient to draw strong conclusions regarding the method of RRT for ARF in septic patients.

Keywords: acute renal failure; sepsis; multiple organ failure; haemopurification; haemofiltration

Published: April 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novák I, Matějovič M, Kroužecký A, Raděj J. Renal replacement therapy in critically ill patients: 2005 update. Anest. intenziv. Med. 2006;17(2):99-101.
Download citation

References

  1. Brivet, F. G., Kleinknecht, D. J., Loirat, P., Landais, P. J. Acute renal failure in intensive care units - causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit. Care Med., 1996, 24, 2, p. 192-198. Go to original source... Go to PubMed...
  2. Tonelli, M., Manns, B., Feller-Kopman, D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am. J. Kidney Dis., 2002, 40, P. 875-885. Go to original source... Go to PubMed...
  3. Dellinger, R. P., Carlet, J. M., Masur, H., Berlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., Ramsay, G., Zimmermann, J. L., Vincent, J. L., Levy, M. M. Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med., 2004, 32, p. 858-873. Go to original source... Go to PubMed...
  4. Gao, F., Melody, T., Daniels, D. F., Gilda, S., Fox, S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Critical Care, 2005, 9, R764-R770. Go to original source... Go to PubMed...
  5. Schrier, R. W., Wang, W., Poole, B., Mitra, A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J. Clin. Invest., 2004, 114, p. 5-14. Go to original source...
  6. Bourgoin, A., Leone, M., Delmas, A., Garnier, F., AlbanŹse, J., Martin, C. Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit. Care Med., 2005, 33, p. 780-786. Go to original source... Go to PubMed...
  7. Morelli, A., Ricci, Z., Bellomo, R., Ronco, C., Rocco, M., Conti, G., De Gaetano, A., Picchini, U., Orecchioni, A., Portieri, M., Coluzzi, F., Porzi, P., Serio, P., Bruno, A., Pietropaoli, P. Prophylactic Fenoldopam for Renal Protection in Sepsis: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial. Crit. Care Med., 2005, 33, 11, p. 2451-2456. Go to original source... Go to PubMed...
  8. Honore, P. M., Jamez, J., Wauthier, M. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome inpatients with intractable circulatory failure resulting from septic shock. Crit. Care Med., 2000, 28, p. 3581-3587. Go to original source... Go to PubMed...
  9. Bellomo, R., Kellum, J. A., Gandhi, C. R., Pinsky, M. R. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am. J. Respir. Crit. Care Med., 2000, 161, p. 1429-1436. Go to original source... Go to PubMed...
  10. Cole, L., Bellomo, R., Journois, D., Davenport, P., Baldwin, I., Tipping, P. High-volume hemofiltration in human septic shock. Intensive Care Med., 2001, 27, p. 978-986. Go to original source... Go to PubMed...
  11. Bouman, C. S., Oudemans van Straaten, H. M., Tijssen, J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective randomized trial. Crit. Care Med., 2002, 30, p. 2205-2211. Go to original source... Go to PubMed...
  12. Morgera, S., Slowinski, T., Melzer, C., Sobottke, V., Vargas-Hein, O., Volk, T., Zuckermann-Becker, H., Wegner, B., Muller, J. M., Baumann, G., Kox, W. J., Bellomo, R., Neumayer, H. H. Renal replacement therapy with high-cut off hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am. J. Kidney Dis., 2004, 43, 3, p. 444-453. Go to original source... Go to PubMed...
  13. Ronco, C., Brendolan, A., Lonnemann, G. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit. Care Med., 2002, 30, p. 1250-1255. Go to original source... Go to PubMed...
  14. Joannes-Boyau, O., Rapaport, S., Bazin, R., Fleureau, C., Janvier, G. Impact of high-volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J., 2004, 50, 1, p. 102-109. Go to original source... Go to PubMed...
  15. Busund, R., Koukline, V., Utrobin, U., Nedashkovsky, E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med., 2002, 28, 10, p. 1434-1439. Go to original source... Go to PubMed...
  16. Kushi, H.. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit. Care, 2005, 9, 6, p. R653-61. Epub 2005 Oct 11. Go to PubMed...
  17. Ronco, C., Bellomo, R., Homel, P., Brendolan, A., Dan, M., Piccinni, P., La Greca, G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet, 2000, 356, p. 26-30. Go to original source... Go to PubMed...
  18. Piccinni, P., Dan, M., Barbarini, S., Carraro, R., Lieta, E., Marafon, S., Zamperetti, N., Brendolan, A., Intini, V., Tetta, C., Bellomo, R., Ronco, C. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med., 2005, [Epub ahead of print]. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.